The 17th Annual Mesothelioma Awareness Day

September 25, 2020 By Erika R. Whitehead

Tomorrow, Sept. 26, marks the 17th annual National Mesothelioma Awareness Day. It was established in 2004 to raise awareness about mesothelioma and increase funding for mesothelioma research. “It was started by a couple of members in our community,” says Maja Belamaric, director of communications and operations for the Mesothelioma Applied Research Foundation (Meso Foundation). “These…

Ask the Doctor: Exploring Mesothelioma Treatment With Dr. Nicholas J. Vogelzang

August 24, 2020 By Erika R. Whitehead

Nicholas J. Vogelzang, M.D., FASCO, FACP, is part of Comprehensive Cancer’s medical oncology team that provides world-class cancer care in a supportive and caring environment. Vogelzang leads and participates in multiple clinical trials in genitourinary malignancies and phase one mesothelioma trials. He also focuses on new therapies for patients with metastatic kidney, bladder and prostate…

The Third Annual MRFJ 5K Begins Next Month!

August 20, 2020 By Erika R. Whitehead

The third annual Mesothelioma Race for Justice (MRFJ) 5K will take place virtually next month from September 1 to September 25. The highly anticipated race will serve as a tribute to National Mesothelioma Awareness Day, and proceeds will be donated to the Mesothelioma Applied Research Foundation (MARF). Public relations manager and union liaison, Mirela Kopier,…

The Need for Consistent Testing Terminology in Oncological Precision Medicine

August 5, 2020 By Erika R. Whitehead

In July, a working group of 41 prestigious patient advocacy organizations, professional societies, pharmaceutical and diagnostic companies, and laboratories, provided recommendations to fellow healthcare officials for the adoption of consistent, plain language terms for biomarker and genetic testing. The goal of the research is to help eliminate patient confusion about precision testing terminology in oncology.…

MRFJ 5K 2020 Shirt and Medal Designs Unveiled!

July 27, 2020 By Erika R. Whitehead

We’re proud to present the brand new shirt and medal designs for the third annual Mesothelioma Race for Justice 5K! “We wanted to illustrate that, though this year’s race is virtual, and each of us may be participating on our own ‘paths’, all of our paths lead to our unified goal of supporting mesothelioma victims…

Optune Lua: The Newest Advancement in Tumor Treating Fields Technology for Malignant Pleural Mesothelioma

June 16, 2020 By Erika R. Whitehead

In May, Optune Lua became the first FDA approved Tumor Treating Fields device designed for use with standard dual drug chemotherapy for patients diagnosed with inoperable malignant pleural mesothelioma. Previously named the NovoTTF-100L System, the portable device was created by Novocure, a global oncology company leading the way in new therapies for solid tumors. Optune…

Load more